← Leaderboards
Alexandru Almasan Almasan
Cleveland Clinic Foundation
$5,940,007
Attributed
$5,940,007
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $418.1K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,940,007 · 5
By mechanism
R01$5,839,392 · 4
P30$100,615 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisCell LineDna DamageEnzyme ActivityRadiation GeneticsProtein Protein InteractionProteolysisTransfectionRadiation ResistanceRegulationNeoplastic CellSignal TransductionMolecularProteinsCellsMultiple MyelomaProtein LocalizationResponseIonizing RadiationApoptoticResistanceGene Induction /RepressionGenetic Promoter ElementDisease /Disorder Model
Grant awards (29)
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy$351,691
R01 · FY2019 · CA · contact PI
Molecular Oncology Research Program$45,085
P30 · FY2019 · CA · contact PI
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy$362,569
R01 · FY2018 · CA · contact PI
Molecular Oncology Research Program$46,272
P30 · FY2018 · CA · contact PI
Molecular Oncology Research Program$9,258
P30 · FY2018 · CA · contact PI
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy$362,569
R01 · FY2017 · CA · contact PI
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy$362,569
R01 · FY2016 · CA · contact PI
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy$362,569
R01 · FY2015 · CA · contact PI
Cdk-2 Independent role of cyclin E in Cell survival$296,611
R01 · FY2013 · CA · contact PI
Cdk-2 Independent role of cyclin E in Cell survival$315,543
R01 · FY2012 · CA · contact PI
Cdk-2 Independent role of cyclin E in Cell survival$315,543
R01 · FY2011 · CA · contact PI
Cdk-2 Independent role of cyclin E in Cell survival$325,302
R01 · FY2010 · CA · contact PI
Cdk-2 Independent role of cyclin E in Cell survival$325,302
R01 · FY2009 · CA · contact PI
Signals for Commitment to Radiation Induces Apoptosis$217,607
R01 · FY2007 · CA · contact PI
Signals for Commitment to Radiation Induces Apaptosis$224,107
R01 · FY2006 · CA · contact PI
Signals for Commitment to Radiation Induces Apaptosis$229,500
R01 · FY2005 · CA
Signals for Commitment to Radiation Induces Apoptosis$229,500
R01 · FY2004 · CA
Signals for Commitment to Radiation Induces Apaptosis$222,520
R01 · FY2003 · CA
CYCLIN E AND GENOTOXIC STRESS INDUCED APOPTOSIS$177,985
R01 · FY2003 · CA
CYCLIN E AND GENOTOXIC STRESS INDUCED APOPTOSIS$42,920
R01 · FY2003 · CA
SIGNALS FOR COMMITMENT TO RADIATION INDUCED APOPTOSIS$178,862
R01 · FY2002 · CA
CYCLIN E AND GENOTOXIC STRESS INDUCED APOPTOSIS$172,801
R01 · FY2002 · CA
CYCLIN E AND GENOTOXIC STRESS INDUCED APOPTOSIS$42,920
R01 · FY2002 · CA
SIGNALS FOR COMMITMENT TO RADIATION INDUCED APOPTOSIS$173,652
R01 · FY2001 · CA
CYCLIN E AND GENOTOXIC STRESS INDUCED APOPTOSIS$167,768
R01 · FY2001 · CA
CYCLIN E AND GENOTOXIC STRESS INDUCED APOPTOSIS$42,920
R01 · FY2001 · CA
CYCLIN E AND GENOTOXIC STRESS INDUCED APOPTOSIS$7,400
R01 · FY2001 · CA
SIGNALS FOR COMMITMENT TO RADIATION INDUCED APOPTOSIS$165,779
R01 · FY2000 · CA
CYCLIN E AND GENOTOXIC STRESS INDUCED APOPTOSIS$162,883
R01 · FY2000 · CA